Vertex Pharmaceuticals Q4 Adj. EPS $1.7 Beats $1.2 Estimate, Sales $1.257B Beat $1.01B Estimate

Vertex Pharmaceuticals (NASDAQ:VRTX) reported quarterly earnings of $1.7 per share which beat the analyst consensus estimate of $1.2 by 41.67 percent. This is a 30.77 percent increase over earnings of $1.3 per share from

Benzinga · 01/30/2020 21:05

Vertex Pharmaceuticals (NASDAQ:VRTX) reported quarterly earnings of $1.7 per share which beat the analyst consensus estimate of $1.2 by 41.67 percent. This is a 30.77 percent increase over earnings of $1.3 per share from the same period last year. The company reported quarterly sales of $1.257 billion which beat the analyst consensus estimate of $1.01 billion by 24.46 percent. This is a 44.58 percent increase over sales of $869.443 million the same period last year.